Dr. Pothuri Discusses Emerging ADCs in HER2-Expressing Endometrial Cancer Targeted Oncology
Adenomyosis is a prevalent disorder of the archimetra, historically conflated with endometriosis but possessing a unique pathobiological trajectory. This review synthesises current molecular evidence to propose a unified mechanistic framework …
Annexin A2 (ANXA2) is a calcium-dependent protein with high affinity for phospholipids, and its multifunctional nature has drawn increasing attention in the onset and progression of various disorders of the …
Endometriosis (EM) is a prevalent gynecological disorder linked to pelvic pain, menstrual disturbances, and infertility. Despite its clinical burden, the molecular mechanisms underlying EM remain elusive, necessitating the discovery of …
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
PORTAL MADNESS: Scott Drew STEALS Elite Kentucky Target, He Wants to DESTROY Mark Pope? newscentermaine.com
Background/Objective: RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), 7-methylguanosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), N4-acetylcytidine (ac4C), 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and adenosine-to-inosine (A-to-I) editing, constitute a critical layer of post-transcriptional regulation that …
GSK sees blockbuster potential in targeted cancer therapy after promising early data KELO-AM
GSK sees blockbuster potential in targeted cancer therapy after promising early data KFGO
GSK sees blockbuster potential in targeted cancer therapy after promising early data WKZO